Rankings
▼
Calendar
TLSI (TriSalus Life Sciences, Inc.) Stock Financials & Earnings | Market Cap Arena
TLSI
TriSalus Life Sciences, Inc.
Mkt Cap
$175M
Healthcare
·
Medical - Devices
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$45M
Net Income (TTM)
-$39M
EPS (TTM)
-$1.83
Free Cash Flow (TTM)
-$19M
Gross Margin
84.6%
Op. Margin
-59.7%
Net Margin
-86.9%
FCF Margin
-41.9%
P/S Ratio (TTM)
3.9x
P/E Ratio (TTM)
—
YoY Rev Growth
+53.4%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Next: Q1 2026 · Apr 6
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$3M
$2M
-$10M
Q2 23
$5M
$4M
-$11M
Q3 23
$5M
$5M
-$19M
Q4 23
$6M
$5M
-$14M
Q1 24
$6M
$5M
-$12M
Q2 24
$7M
$6M
-$8M
Q3 24
$7M
$6M
-$9M
Q4 24
$8M
$7M
-$8M
Q1 25
$9M
$8M
-$7M
Q2 25
$11M
$9M
-$7M
Q3 25
$12M
$10M
-$9M
Q4 25
$13M
$11M
-$3M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
13.5x
—
Q2 23
11.9x
—
Q3 23
10.9x
—
Q4 23
9.5x
—
Q1 24
8.0x
—
Q2 24
7.1x
—
Q3 24
6.5x
—
Q4 24
6.0x
—
Q1 25
5.4x
—
Q2 25
4.9x
—
Q3 25
4.4x
—
Q4 25
3.9x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$11M
-$11M
Q2 23
-$9M
-$9M
Q3 23
-$22M
-$22M
Q4 23
-$9M
-$10M
Q1 24
-$11M
-$11M
Q2 24
-$13M
-$13M
Q3 24
-$11M
-$11M
Q4 24
-$6M
-$6M
Q1 25
-$4M
-$5M
Q2 25
-$7M
-$7M
Q3 25
-$4M
-$4M
Q4 25
-$2M
-$3M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$74K
Q2 23
$30K
Q3 23
$178K
Q4 23
$700K
Q1 24
$66K
Q2 24
$60K
Q3 24
$169K
Q4 24
$50K
Q1 25
$754K
Q2 25
$93K
Q3 25
$216K
Q4 25
$41K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+25.9%
+27.7%
Q2 23
+60.3%
+39.0%
Q3 23
+32.4%
+97.8%
Q4 23
+77.3%
+32.3%
Q1 24
+116.4%
+38.4%
Q2 24
+59.7%
-3.2%
Q3 24
+41.5%
-32.4%
Q4 24
+44.4%
-20.2%
Q1 25
+42.0%
-9.1%
Q2 25
+52.3%
+19.4%
Q3 25
+57.4%
+27.9%
Q4 25
+59.8%
+4.0%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$74K
2.5%
Q2 23
$68K
1.5%
Q3 23
$0
0.0%
Q4 23
$1M
17.5%
Q1 24
$1M
16.8%
Q2 24
$1M
17.3%
Q3 24
$1M
18.8%
Q4 24
$2M
20.5%
Q1 25
$2M
17.7%
Q2 25
$2M
16.9%
Q3 25
$3M
29.6%
Q4 25
$2M
16.6%
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
Quarter
R&D
G&A
S&M
Q1 23
$6M
$4M
$3M
Q2 23
$7M
$5M
$3M
Q3 23
$10M
$9M
$5M
Q4 23
$8M
$6M
$6M
Q1 24
$6M
$5M
$7M
Q2 24
$5M
$4M
$6M
Q3 24
$4M
$5M
$6M
Q4 24
$3M
$5M
$7M
Q1 25
$3M
$5M
$7M
Q2 25
$4M
$6M
$7M
Q3 25
$5M
$7M
$7M
Q4 25
$3M
$4M
$8M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$7M
$0
$7M
Q2 23
$4M
$0
$4M
Q3 23
$21M
$0
$21M
Q4 23
$12M
$0
$12M
Q1 24
$4M
$0
$4M
Q2 24
$16M
$0
$16M
Q3 24
$11M
$0
$11M
Q4 24
$9M
$0
$9M
Q1 25
$13M
$0
$13M
Q2 25
$26M
$0
$26M
Q3 25
$23M
$0
$23M
Q4 25
$20M
$0
$20M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
26M
-10.6%
Q2 23
26M
+0.0%
Q3 23
26M
+0.0%
Q4 23
26M
+0.0%
Q1 24
23M
-11.9%
Q2 24
24M
+2.5%
Q3 24
27M
+10.9%
Q4 24
27M
+0.0%
Q1 25
29M
+7.6%
Q2 25
33M
+15.3%
Q3 25
43M
+30.9%
Q4 25
47M
+8.8%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 20
—
—
FY 21
—
—
FY 22
—
—
FY 23
—
—
FY 24
$268K
110
FY 25
$470
96K
marketcaparena.com